Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

被引：1

作者：

Logothetis, Christopher J. ^{[1
]}

Siefker-Radtke, Arlene ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Unit 1374, Dept Genitourinary Med Oncol, Houston, TX 77230 USA

来源：

EUROPEAN UROLOGY | 2010年 / 57卷 / 04期

关键词：

D O I：

10.1016/j.eururo.2010.01.029

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：728 / 729

页数：3

共 50 条

[1] Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium
Milowsky, Matthew I.
Nanus, David M.
Maluf, Fernando C.
Mironov, Svetlana
Shi, Weiji
Iasonos, Alexia
Riches, Jamie
Regazzi, Ashley
Bajorin, Dean F.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4062 - 4067
[2] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
Ecke, Thorsten H.
Bartel, Peter
Koch, Stefan
Ruttloff, Juergen
Theissig, Franz
ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
[3] Phase I evaluation of sequential doxorubicin plus gemcitabine then ifosfamide plus paclitaxel plus cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
Dodd, PM
McCaffrey, JA
Hilton, S
Mazumdar, M
Herr, H
Kelly, WK
Icasiano, E
Boyle, MG
Bajorin, DF
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 840 - 846
[4] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with infiltrative transitional cell carcinoma of the urothelium
Ecke, T. K.
Bartel, P.
Theissig, F.
Koch, S.
Ruttloff, J.
EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 220 - 220
[5] A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer Final Results
Siefker-Radtke, Arlene O.
Dinney, Colin P.
Shen, Yu
Williams, Dallas L.
Kamat, Ashish M.
Grossman, H. Barton
Millikan, Randall E.
CANCER, 2013, 119 (03) : 540 - 547
[6] Re: A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results Editorial Comment
Wood, David P.
JOURNAL OF UROLOGY, 2013, 190 (06): : 2019 - 2019
[7] Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin for Kidney Transplant Patients With Locally Advanced Transitional Cell Carcinoma
Wang, Z. P.
Wang, W. Y.
Zhu, Y. C.
Xiao, J.
Lin, J.
Guo, Y. W.
Tian, Y.
TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2076 - 2079
[8] A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
von der Maase, H.
Lehmann, J.
Gravis, G.
Joensuu, H.
Geertsen, P. F.
Gough, J.
Chen, G.
Kania, M.
ANNALS OF ONCOLOGY, 2006, 17 (10) : 1533 - 1538
[9] Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
Dogliotti, Luigi
Carteni, Giacomo
Siena, Salvatore
Bertetto, Oscar
Martoni, Andrea
Bono, Aldo
Amadori, Dino
Onat, Haluk
Marini, Luca
EUROPEAN UROLOGY, 2007, 52 (01) : 134 - 141
[10] Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy
K S Han
J Y Joung
T S Kim
I G Jeong
H K Seo
J Chung
K H Lee
British Journal of Cancer, 2008, 98 : 86 - 90

← 1 2 3 4 5 →